Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Anita Steinbakk"'
Autor:
Anita Steinbakk, Anais Malpica, Aida Slewa, Einar Gudlaugsson, Emiel A. M. Janssen, Mark Arends, Arnold Jan Kruse, Yu Yinhua, Weiwei Feng, Jan P. Baak
Publikováno v:
Analytical Cellular Pathology, Vol 33, Iss 5-6, Pp 245-255 (2010)
Objectives: To analyze the prognostic value of microsatellite instability (MSI) in a population-based study of FIGO stage 1–4 endometrial endometrioid adenocarcinomas.
Externí odkaz:
https://doaj.org/article/6872199c92544ef6bad498bff753be60
Autor:
Anita Steinbakk, Bianca van Diermen, Einar Gudlaugsson, Emiel A. M. Janssen, Jan P. A. Baak, Emma Rewcastle, Ivar Skaland, Anne Elin Varhaugvik
Publikováno v:
Endocrine-related cancer. 25(12)
In order to avoid the consequences of over- and under-treatment of endometrial hyperplasia, diagnostic accuracy and progression risk assessment must be improved. The aim of this study was to assess whether PAX2 or PTEN expression could predict progre
Autor:
Weiwei Feng, Emiel A. M. Janssen, Aida Slewa, Arnold-Jan Kruse, Anita Steinbakk, Jan P. A. Baak, Einar Gudlaugsson, Yu Yinhua, Anais Malpica, Mark P. Arends
Publikováno v:
Analytical Cellular Pathology (Amsterdam)
Analytical Cellular Pathology, Vol 33, Iss 5-6, Pp 245-255 (2010)
Cellular oncology, 34(5), 457-465. Springer
Analytical Cellular Pathology, Vol 33, Iss 5-6, Pp 245-255 (2010)
Cellular oncology, 34(5), 457-465. Springer
Objectives: To analyze the prognostic value of microsatellite instability (MSI) in a population-based study of FIGO stage 1–4 endometrial endometrioid adenocarcinomas.Study Design: Survival analysis in 273 patients of MSI status and clinico-patholo
Autor:
Arnold-Jan Kruse, Kjell Løvslett, Aida Slewa, Anita Steinbakk, Yu Yinhua, Ivar Skaland, Anais Malpica, Weiwei Feng, Emiel A. M. Janssen, Einar Gudlaugsson, Bent Fiane, Jan P. A. Baak
Publikováno v:
Modern Pathology, 24(9), 1262-1271. Nature Publishing Group
The prognostic value of molecular biomarkers, microsatellite instability, DNA ploidy and morphometric mean shortest nuclear axis in endometrial cancer is conflicting, possibly due to the fact that different studies have used mixtures of histotypes, F
Autor:
Anita Steinbakk, George L. Mutter, Kjell Løvslett, Bent Fiane, Ivar Skaland, Jan P. A. Baak, Bianca van Diermen, Emiel A. M. Janssen
Publikováno v:
Human pathology. 36(5)
We tested the hypothesis that PTEN inactivation may stratify cancer progression risk among putative endometrial hyperplasias, classified prognostically by means of the morphometric D score (DS). The DS, calculated from 3 morphometric variables measur
Autor:
Paul J. van Diest, Tove Helliesen, R.H.M. Verheijen, Kjell-Henning Kjellevold, George L. Mutter, Luly Taddele, Bent Fiane, Jan P. A. Baak, Kjell Løvslett, Bianca van Diermen, Anita Steinbakk, Peter Kenemans, Curt W. Burger
Publikováno v:
Cancer Chemoprevention ISBN: 9781588290779
Endometrial hyperplasia (EH) is a common disease. An estimated 180,000–200,000 new cases occur annually in the Western world; approx 39,200 new cases and 6600 deaths were expected in the United States in 2002 (1). About 8–20% of all EH is associa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58c1947965a36af457351a3391014abd
https://doi.org/10.1007/978-1-59259-768-0_34
https://doi.org/10.1007/978-1-59259-768-0_34
Autor:
Anais Malpica, Einar Gudlaugsson, Jan P. A. Baak, Ivar Skaland, Weiwei Feng, Emiel A. M. Janssen, Ole Gunnar Aasprong, Anita Steinbakk
Publikováno v:
American Journal of Obstetrics and Gynecology. 204:357.e1-357.e12
The purpose of this study was to assess the value of the 2003 World Health Organization (WHO) and endometrial intraepithelial neoplasia (EIN) classifications, D-score, and molecular biomarkers in endometrial hyperplasia (EH) for cancer progression.We
Autor:
Jan P. A. Baak, Anita Steinbakk, Emiel A. M. Janssen, Ivar Skaland, Bent Fiane, Kjell H. Kjellevold, Kjell Løvslett, Jan Klos, Einar Gudlaugsson
Publikováno v:
American Journal of Obstetrics and Gynecology. 200:78.e1-78.e8
Objective To analyze the prognostic value of molecular biomarkers in curettages of endometrioid endometrial cancer pathologic FIGO stages 1 and 2. Study Design Population-based survival analysis in 258 patients of classical prognostic features and mo